Your browser doesn't support javascript.
loading
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic.
Kyrou, Ioannis; Karteris, Emmanouil; Robbins, Tim; Chatha, Kamaljit; Drenos, Fotios; Randeva, Harpal S.
  • Kyrou I; Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK.
  • Karteris E; Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham, B4 7ET, UK.
  • Robbins T; Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
  • Chatha K; College of Health and Life Sciences, Brunel University London, Uxbridge, UB8 3PH, UK.
  • Drenos F; Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK.
  • Randeva HS; Institute of Digital Healthcare, WMG, University of Warwick, Coventry, CV4 7AL, UK.
BMC Med ; 18(1): 220, 2020 07 15.
Article en En | MEDLINE | ID: mdl-32664957

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Síndrome del Ovario Poliquístico / Infecciones por Coronavirus Tipo de estudio: Etiology_studies / Guideline / Prevalence_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Síndrome del Ovario Poliquístico / Infecciones por Coronavirus Tipo de estudio: Etiology_studies / Guideline / Prevalence_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article